Suchergebnisse - "Cattrini, Carlo"

PubPharm (63)

1

TEAM Study : Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis

enthalten in: Clinical genitourinary cancer | 2024

von Pisano, C. | Turco, F. | Arnaudo, E. | +27

2

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer : A Quantitative Synthesis and Meta-analysis

enthalten in: European urology oncology | 2024

von Messina, C. | Giunta, E. | Signori, A. | +11

3

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors : A Systematic Review and Meta-Analysis

enthalten in: JAMA network open | 2024

von Maiorano, B. | Di Maio, M. | Cerbone, L. | +104

4

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma : insights from the RELIEVE study's analysis of heavily pretreated patients

enthalten in: Therapeutic advances in urology | 2024

von Buti, S. | Olivari, A. | Masini, C. | +20

5

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations : Differential Effectiveness by Risk Group?

enthalten in: European urology oncology | 2024

von Santoni, M. | Buti, S. | Myint, Z. | +63

6

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma : data from the ARON-2 retrospective study

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Fiala, O. | Buti, S. | Takeshita, H. | +89

7

Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients

enthalten in: Scientific reports | 2023

von Cattrini, C. | Manfredi, M. | Barboro, P. | +13

8

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

enthalten in: Clinical genitourinary cancer | 2023

von Santoni, M. | Massari, F. | Myint, Z. | +53

9

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations

enthalten in: Minerva urology and nephrology | 2023

von Porta, C. | Bamias, A. | Zakopoulou, R. | +63

10

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma : The ARON-1 Study

enthalten in: Targeted oncology | 2023

von Santoni, M. | Massari, F. | Myint, Z. | +53

1
2
3
4
5
6
7
Nächster »
[7]